Profile | GDS4284 / 241696_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 195.085 | 49 |
GSM687648 | Patient 402 control | 89.2668 | 33 |
GSM687653 | Patient 403 control | 9.11259 | 5 |
GSM687658 | Patient 404 control | 160.119 | 44 |
GSM687663 | Patient 411 control | 154.601 | 42 |
GSM687668 | Patient 422 control | 15.5023 | 9 |
GSM687673 | Patient 424 control | 176.62 | 45 |
GSM687678 | Patient 425 control | 146.42 | 41 |
GSM687683 | Patient 427 control | 1025.57 | 74 |
GSM687688 | Patient 428 control | 203.504 | 49 |
GSM687695 | Patient 441 control | 171.776 | 36 |
GSM687699 | Patient 443 control | 151.664 | 39 |
GSM687704 | Patient 444 control | 42.0015 | 21 |
GSM687707 | Patient 448 control | 3.93997 | 1 |
GSM687712 | Patient 449 control | 293.328 | 55 |
GSM687719 | Patient 450 control | 204.059 | 45 |
GSM687724 | Patient 451 control | 72.2389 | 26 |
GSM687728 | Patient 452 control | 290.935 | 54 |
GSM687646 | Patient 401 treated 24h | 441.801 | 61 |
GSM687649 | Patient 402 treated 24h | 200.486 | 50 |
GSM687665 | Patient 411 treated 24h | 194.161 | 46 |
GSM687651 | Patient 402 treated 4 weeks | 363.174 | 58 |
GSM687667 | Patient 411 treated 4 weeks | 183.487 | 46 |
GSM687670 | Patient 422 treated 24h | 95.1725 | 32 |
GSM687671 | Patient 422 treated 4 weeks | 13.368 | 8 |
GSM687654 | Patient 403 treated 24h | 2.49032 | 1 |
GSM687675 | Patient 424 treated 24h | 108.199 | 34 |
GSM687685 | Patient 427 treated 24h | 391.634 | 60 |
GSM687656 | Patient 403 treated 4 weeks | 25.2673 | 16 |
GSM687677 | Patient 424 treated 4 weeks | 213.797 | 50 |
GSM687687 | Patient 427 treated 4 weeks | 524.077 | 64 |
GSM687692 | Patient 428 treated 4h | 286.239 | 55 |
GSM687716 | Patient 449 treated 4h | 380.446 | 60 |
GSM687722 | Patient 450 treated 4h | 98.6228 | 31 |
GSM687680 | Patient 425 treated 24h | 142.28 | 41 |
GSM687690 | Patient 428 treated 24h | 541.129 | 66 |
GSM687700 | Patient 443 treated 24h | 213.292 | 42 |
GSM687705 | Patient 444 treated 24h | 55.1919 | 25 |
GSM687714 | Patient 449 treated 24h | 259.718 | 54 |
GSM687721 | Patient 450 treated 24h | 194.558 | 44 |
GSM687682 | Patient 425 treated 4 weeks | 514.348 | 65 |
GSM687694 | Patient 428 treated 4 weeks | 303.408 | 56 |
GSM687702 | Patient 443 treated 4 weeks | 153.53 | 41 |
GSM687718 | Patient 449 treated 4 weeks | 530.85 | 65 |
GSM687723 | Patient 450 treated 4 weeks | 368.271 | 58 |
GSM687661 | Patient 404 treated 4h | 6.04568 | 2 |
GSM687710 | Patient 448 treated 4h | 85.4792 | 31 |
GSM687726 | Patient 451 treated 4h | 120.109 | 35 |
GSM687730 | Patient 452 treated 4h | 651.162 | 63 |
GSM687660 | Patient 404 treated 24h | 175.708 | 41 |
GSM687697 | Patient 441 treated 24h | 412.904 | 58 |
GSM687709 | Patient 448 treated 24h | 13.3847 | 7 |
GSM687725 | Patient 451 treated 24h | 27.321 | 12 |
GSM687729 | Patient 452 treated 24h | 294.984 | 51 |
GSM687727 | Patient 451 treated 4 weeks | 16.2622 | 7 |
GSM687731 | Patient 452 treated 4 weeks | 390.599 | 59 |